Replies to post #17071 on Value Microcaps Motherboard

[Guy]

Cliff, if VPHM was to amortize the cost of Vancocin
over a 12.5 year period, the impact on the bottom line
would be approx another .002 and not .02 like you said.
(additional $105k/50 million shares)

Also, 2c a share is a big deal for a company that
makes .36 per Q.

>>Just checked, Q1 diluted earnings would have been reduced from 36c to 34c if the cost of Vancocin was amortized over 12.5 years instead of 25 years. So not a big issue.<<